The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Carnisone Increases Efficiency of DOPA Therapy of Parkinson's Disease: A Pilot Study
Abstract
The addition of the neuropeptide carnosine ( β -alanyl-L-histidine) as a food additive to the basic protocol of Parkinson's disease treatment results in significant improvement of neurological symptoms, along with increase in red blood cell Cu/Zn-SOD and decrease in blood plasma protein carbonyls and lipid hydroperoxides, with no noticeable change in platelets MAO B activity. The combination of carnosine with basic therapy may be a useful way to increase efficiency of PD treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Parkinson’s patients with trembling manifestations taking basic treatment with Levodopa and dopamine-receptor agonists plus oral carnosine supplementation showed enhanced efficiency of basic therapy against PD, manifested by restored levels of superoxide dismutase, typically lowered in patients (Boldyrev et al. 2008).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Boldyrev et al. 2008
Citations
Cites
Misra, H. P., & Fridovich, I. (1972) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45228-9 · Cited by 9,097
Unified Parkinson's Disease Rating Scale
(2012) · Springer eBooks · doi:10.1007/springerreference_184495 · Cited by 3,071
Glantz, S. A. (1981) · Cited by 2,636
Recent developments in Parkinson's disease
Fahn, S., Elton, R., MARSDEN, C. D., Calne, D. B., & Goldstein, M. (1986) · Raven Press eBooks · Cited by 2,306
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,674
Neuropathology of Parkinson's Disease
Forno, L. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199603000-00001 · Cited by 1,556
Samii, A., Nutt, J. G., & Ransom, B. R. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16305-8 · Cited by 1,361
Oxidative stress and the pathogenesis of Parkinson's disease
Jenner, P., & Olanow, C. W. (1996) · Neurology · doi:10.1212/wnl.47.6_suppl_3.161s · Cited by 971
A radical hypothesis for neurodegeneration
Olanow, C. W. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90070-3 · Cited by 722
THE BIOCHEMISTRY OF PARKINSON'S DISEASE
Cookson, M. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133400 · Cited by 666
Flagged first, then by citations
1 of the 29 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–123 of 123
CARNOSINE-CONTAINING LIPOSOMES: PREPARATION AND PROPERTIES
Antonova, N. A., Sorokoumova, G. M., Федорова, Т. Н., Stvolynsky, S. L., Абаимов, Д. А., Попенко, В. И., & Швец, В. И. (2016) · Fine Chemical Technologies · doi:10.32362/2410-6593-2018-13-2-55-62 · Cited by 4
Makletsova, M. G., Rikhireva, G. T., Poleschuk, V. V., Грякалов, К. В., Timerbaeva, S. L., & Федорова, Т. Н. (2016) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20166202193 · Cited by 4
Stvolinsky, S. L., Федорова, Т. Н., Berezhnoy, D. S., Logvinenko, A., Muzychuk, O. A., & Inozemtsev, A. A. (2014) · Neurochemical Journal · doi:10.1134/s1819712414040096 · Cited by 4
“Carnosine-Niosomal Delivery System for Targeted Cancer Therapy”
Atta, A., Salem, M. M., Reda, A., & Mohamed, T. M. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01626-w · Cited by 3
Ferroptosis-related stress during aging and its relevance to disease
Maher, P. A., Soriano‐Castell, D., Dar, N. J., Soriano, S., & Currais, A. J. M. (2025) · GeroScience · doi:10.1007/s11357-025-01929-7 · Cited by 6
SYNTHESIS OF DEUTERIUM-LABELED PYRROLYLCARNOSINE
Shevchenko, V. P., Nagaev, I. Y., Федорова, Т. Н., & Myasoedov, N. F. (2023) · Доклады Российской академии наук Науки о жизни · doi:10.31857/s2686738922700020 · Cited by 3
2-Oxo-imidazole-containing dipeptides resist degradation by carnosinase 1
Komae, S., Kasamatsu, S., Moritsugu, K., Uchida, K., & Ihara, H. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.11.014 · Cited by 2
Privitera, A., Cardaci, V., Zupan, M. C., Pietro, L. D., Carota, G., Sibbitts, J., Mangione, R., Graziani, A., Buccarello, L., Bellia, F., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1768094 · Cited by 2
Stvolinsky, S. L., Antonova, N. A., Игоревна, К. О., Lopachev, A. V., Абаимов, Д. А., Al-Baidani, I., Lopacheva, O. M., Федорова, Т. Н., Kaplun, A. P., & Sorokoumova, G. M. (2018) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s199075081804008x · Cited by 2
Hipkiss, A. R. (2019) · Journal of Aging Science · Cited by 2
Application of Carnosine and Its Functionalised Derivatives
Chevalot, I., Arab‐Tehrany, E., Husson, É., & Gérardin‐Charbonnier, C. (2016) · doi:10.1002/9783527681754.ch15 · Cited by 2
Федорова, Т. Н., Игоревна, К. О., Migulin, V. A., Muzychuk, O. A., Абаимов, Д. А., & Stvolinsky, S. L. (2024) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-024-03185-z · Cited by 1
Makletsova, M. G., Rikhireva, G. T., Poleschuk, V. V., & Illarioshkin, S. N. (2017) · BIOPHYSICS · doi:10.1134/s0006350917060148 · Cited by 1
Self-citationSynthesis of Deuterium-Labeled Pyrrolylcarnosine
Shevchenko, V. P., Nagaev, I. Y., Федорова, Т. Н., & Myasoedov, N. F. (2022) · Doklady Biochemistry and Biophysics · doi:10.1134/s1607672922340130 · Cited by 1
Creating a protein-protein interaction network for alpha-synuclein
Könn, M. (2012) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-7491 · Cited by 1
Sakae, K., & Yanagisawa, H. (2014) · Biomedical research on trace elements · doi:10.11299/brte.25.106
Molecular Medicine & Therapeutics
Hipkiss, A. R. (2012)
Makletsova, M. G., Rikhireva, G. T., Poleschuk, V. V., Грякалов, К. В., Timerbaeva, S. L., & Федорова, Т. Н. (2016) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750816030124
Resolving Geroplasticity to the Balance of Rejuvenins and Geriatrins
TABIBZADEH, S. S. (2022) · Aging and Disease · doi:10.14336/ad.2022.0414
Meena, M. B., Meena, M., Saini, S., Gupta, N. K., Godika, S., Pilania, S., Sharma, R., & Saini, A. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.146993
Wurtz, L. I., Knyazhanskaya, E. E., Sohaei, D., Prassas, I., Pittock, S., Willrich, M. A. V., Saadeh, R., Gupta, R., Atkinson, H. J., Grill, D. E., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26047018
Kamphuis, J. B. J. (2019) · theses.fr (ABES) · doi:10.70675/e4003e6fzeffaz48a2z95a6zba874fe5eb4c
O’Toole, T. E., Wingard, C. J., Bariess, S. K., Crandell, C. E., Amraotkar, A. R., Gao, H., & Bhatnagar, A. (2026) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2026.2679716
Metadata
- Authors
- Boldyrev, A., Fedorova, T., Stepanova, M., Dobrotvorskaya, I., Kozlova, E., Boldanova, N., Bagyeva, G., Ivanova-Smolenskaya, I., & Illarioshkin, S.
- Affiliations
- Research Center of Neurology, Russian Academy of Medical Sciences, Moscow, Russia.
- Research Center of Neurology (RU)
- Russian Academy of Sciences (RU)
- ORCID
- Stepanova, Maria
- Venue
- Rejuvenation Research
- Publisher
- SAGE Publications
- Published
- 2008-08
- Volume
- 11
- Issue
- 4
- Pages
- 821-827
- ISSN
- 1094-5458 (ISSN-L)
- 1549-1684
- 1557-8577
- OpenAlex
- W1978715967
- Cited by
- 123
- References
- 29
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 5 · 2023: 10 · 2022: 5 · 2021: 13 · 2020: 10 · 2019: 8 · 2018: 11 · 2017: 6 · 2016: 14 · 2015: 6 · 2014: 7 · 2013: 6 · 2012: 4
- FWCI
- 2.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Rejuvenation Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Academy of Medical Sciences
- Russian Academy of Sciences
- Topics
- Health Sciences › Medicine › Physiology (medical) › Biochemical effects in animals
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Keywords
- carnosine, Parkinson's disease, combination therapy, copper-zinc superoxide dismutase, protein carbonyls, lipid hydroperoxides, oxidative stress, neuroprotection
- MeSH terms
- Adult, Aged, Carnosine, Dihydroxyphenylalanine, Drug Synergism, Female, Humans, Male, Middle Aged, Monoamine Oxidase, Parkinson Disease, Pilot Projects, Superoxide Dismutase, Treatment Outcome, Oxidative Stress, Protein Carbonylation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
